Perspectives on variability of in vivo toxicology studies: considerations for next-generation toxicology
While any test system will have inherent variability, understanding its sources and impact on study interpretation will help ensure that appropriate confidence is applied when using the test method. Furthermore, such information aids in establishing relevant metrics to serve as baselines for informing performance characterization of new approach methodologies (NAMs). Future evaluation of NAMs should be contextualized using estimates of uncertainty and variance of the traditional study data to demonstrate "better" performance compared to traditional testing approaches. Robust understanding of guideline study performance is important for risk assessments, where it is important to find species-relevant NAMs that can perform at least as well as existing bioassays.
Authors
- Emily N. Reinke
- Agnes L. Karmaus (ORCID: https://orcid.org/0000-0003-4421-6164)
- Helena T. Högberg (ORCID: https://orcid.org/0000-0001-8034-6818)
- Nicole Kleinstreuer (ORCID: https://orcid.org/0000-0002-7914-3682)
- Anna Kreutz
- Oluwakemi Oyetade
- David Allen
Institutions
- Research Triangle Park Foundation (US)
- Innsbruck Medical University (AT)
- Society of Environmental Toxicology and Chemistry (US)
Publication Details
- Journal
- Frontiers in Toxicology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3389/ftox.2026.1778353
- Primary Topic
- Animal testing and alternatives
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medizinische Universität Innsbruck
- Universität Innsbruck
- National Institutes of Health